BMC Neuroscience

official impact factor 3.09

This article is part of the supplement: Proceedings of the 8th International Conference on Alzheimer's Disease Drug Discovery

Open Access Highly Access

Hypometabolism as a therapeutic target in Alzheimer's disease

Lauren C Costantini*, Linda J Barr, Janet L Vogel and Samuel T Henderson

BMC Neuroscience 2008, 9(Suppl 2):S16 doi:10.1186/1471-2202-9-S2-S16

Accesses  

  • Last 30 days: 161 accesses
  • Last 365 days: 1620 accesses
  • All time: 6029 accesses

Cited by

BioMed Central: 2 citations